Proto Labs stock
PRLBNYSEProto Labs, Inc., IndustrialsISIN US7437131094
54Score 54 out of 100, Neutral
Price and trend
49 / 100
Price history
+38% in one yearThe chart shows daily closes over 15 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Below the 200-day line: the price is 7.0% below it.
Since November 2024 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 31).
The price is 30% below its 52-week high. Largest decline in 15 years: 91% (January 2021 to November 2022).
Chart figures for advanced users
- SMA 50$84.19
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$73.80
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)31
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$46.81
- The lowest closing price of the last twelve months.
- Resistance$98.68
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- In fiscal 2025 it reported revenue of $533.13M (up 6.4% year on year) and earnings of $21.24M (up 28%).
- For fiscal 2026, analysts expect on average revenue of $590.6M (up 10.8%) and adjusted earnings per share of $2.27 (up 37.3%).
- MEQIRI Score 54 out of 100 (Neutral): rank 728 of 1023 in Industrials, median 61.
Show more
- The P/E is 47.9 (Industrials sector median 22.7, own median of recent years 53.1).
- Our model puts fair value at $42.13, with the price 64% above it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- More cash than debtCash $151.15M, financial debt $3.9M.Stability 84
- Share buybacksShare count down 11% since 2020.Capital allocation 60
- Earnings turn into cashFree cash flow 139% of earnings over the last 12 months.Fundamentals 79
Weaknesses
- Earnings per share fallingDown 14.1% a year since 2020.Growth 28
- Volatile share priceVolatility 50% a year over the last 12 months.
Its standout strengths are stability and fundamentals, while growth and valuation hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- high price swings
What lowers it
- solid fundamentals
Valuation
Valuation signal
Modestly overvaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $30.10 and expensive above $70.22 (uncertainty high, based on the price swings of the past year).
The two parts of the fair value come to $51.71 (cash-flow model) and $32.56 (industry comparison), and the gap between them shows how uncertain the estimate is. The price is above both.
Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $37.89, at 7.8% it would be $48.50.
Valuation metrics
Half from the cash-flow model, half from earnings times the sector P/E (22.7).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Sep 2026, revenue rose 11.8% on the twelve months before. Revenue has grown strongly since 2009, at around 17% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 44%, operating 5%, net 4%.
Debt & balance sheet
latest quarterThe balance sheet is solid, with low debt and comfortable interest coverage.
Earnings
- Next earnings
- 5 Feb 2027in 85 days
- Last reported
- 29 Oct 2026EPS reported $0.63 (expected $0.60)above expectations
Analyst estimates
Analysts have raised their 2027 earnings estimate by 5.2% since 15 Oct 2026.
- Earnings per share
- $2.27+2.3%
- Revenue
- $590.6M+1.4%
- Earnings per share
- $2.51+5.2%
- Revenue
- $632.1M+0.9%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook raised
Share price after the results: −24.2%Protolabs raised its full year 2026 revenue growth outlook from 8% to 10% to a new range of 10% to 11%.
“As a result, we are raising our full year 2026 revenue growth outlook from a prior range of 8% to 10% to a new range of 10% to 11%. We anticipate 2026 will be our first year of double-digit organic revenue growth since 2018.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Oct 2026 (fiscal Q3 2026), read by AI.
Insiders
Open-market purchases and sales by executives, board members and major holders
2 insiders bought on the open market in the last 6 months, $101,230 in total. 2 insiders sold, $1.06M in total.
Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.
Partial trades from one filing are shown in one row, with the average price.
Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.
What happened at Proto Labs
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
1023 rated companies in Industrials
- This company
- 54
- Sector median
- 61
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in the Industrials sector
The next larger and next smaller companies by market value
ETFs that hold Proto Labs
Held by 15 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares S&P SmallCap 600 UCITS ETFIUS3 | 0.09% | 0.30% | €2.28B |
| iShares Automation & Robotics UCITS ETF2B76 | 0.09% | 0.40% | €4.49B |
| L&G Russell 2000 US Small Cap Quality UCITS ETFETLZ | 0.09% | 0.30% | €185.82M |
Show 5 more
| Xtrackers Russell 2000 UCITS ETF 1CXRS2 | 0.06% | 0.30% | €2.17B |
| State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc)ZPRR | 0.05% | 0.30% | €4.22B |
| Amundi MSCI Robotics & AI UCITS ETF AccGOAI | 0.03% | 0.40% | €1.14B |
| Amundi MSCI Digital Economy UCITS ETF AccEBUY | 0.03% | 0.45% | €96.36M |
| iShares MSCI World Small Cap UCITS ETFIUSN | 0.01% | 0.35% | €8.19B |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 30 Nov 2023)
- Valuation signal Fairly valued since 8 Nov 2026, previously Overvalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.